Human Serum Amyloid P Component is a Single Uncomplexed Pentamer in Whole Serum

BackgroundSerum amyloid P component (SAP) is a universal constituent of amyloid deposits and contributes to their pathogenesis. SAP also has important normal functions in the handling of chromatin in vivo and resistance to bacterial infection. The atomic resolution crystal structure of SAP is known, but its physiological oligomeric assembly remains controversial. In the absence of calcium, isolated human SAP forms stable decamers composed of two cyclic disk-like pentamers interacting face to face. However, in the presence of its specific low molecular weight ligands and calcium, SAP forms stable pentamers. In the presence of calcium, but without any ligand, isolated human SAP aggressively autoaggregates and precipitates, imposing severe constraints on methods for molecular mass determination.Materials and MethodsGel filtration chromatography and density gradient ultracentrifugation were used to compare SAP with the closely related molecule, C-reactive protein (CRP; which is known to be a single pentamer) and the effect of human serum albumin on SAP autoaggregation was investigated.ResultsIn most physiological buffers and with the necessary absence of calcium, SAP, whether isolated or from whole serum samples, eluted from gel filtration columns clearly ahead of CRP. This is consistent with the existence of a monodisperse population of SAP decamers, as previously reported. However, in Tris/phosphate buffer, SAP was pentameric, suggesting that decamerization involved ionic interactions. On density gradients formed in undiluted normal human serum, SAP sedimented as single pentamers not complexed with any macromolecular ligand, regardless of the presence or absence of calcium. The calcium-dependent autoaggregation of isolated SAP was completely inhibited by physiological concentrations of albumin and the SAP remained pentameric.ConclusionsHuman SAP exists within serum as single uncomplexed pentamers in the presence or absence of calcium. This oligomeric assembly, thus, does not require a calcium-dependent small molecule interaction. The usual >2000-fold molar excess of albumin over SAP in plasma is apparently sufficient to keep SAP in its physiological conformation.

• Publication year

  2000

• Venue

  Molecular Medicine

• Publication date

  2000-02-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF03401789PMID 10972085PMCID PMC1949963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The physiological structure of human C-reactive protein and its complex with phosphocholine.

  1999cited by this paper
• Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity

  1999cited by this paper
• Amyloid P component. A critical review

  1997cited by this paper
• Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene

  1997cited by this paper
• Pentameric and decameric structures in solution of serum amyloid P component by X-ray and neutron scattering and molecular modelling analyses.

  1997influential reference
• Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP.

  1997cited by this paper
• Three dimensional structure of human C-reactive protein

  1996cited by this paper
• Native Human Serum Amyloid P Component is a Single Pentamer

  1995influential reference
• Comparative analyses of pentraxins: implications for protomer assembly and ligand binding.

  1995cited by this paper
• Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.

  1995cited by this paper
• Serum Amyloid P Component Binding to C4b-binding Protein (*)

  1995cited by this paper
• Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.

  1994cited by this paper
• Structure of pentameric human serum amyloid P component

  1994cited by this paper
• Interaction between serum amyloid P component and C4b-binding protein associated with inhibition of factor I-mediated C4b degradation.

  1994cited by this paper
• Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.

  1993cited by this paper
• Serum amyloid P component in chronic renal failure and dialysis.

  1991cited by this paper
• Heparin influence on the complex of serum amyloid P component and complement C4b-binding protein.

  1991cited by this paper
• Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis

  1991cited by this paper
• Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.

  1990cited by this paper
• Pentraxin-chromatin interactions: serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin

  1990cited by this paper
• Independent association of serum amyloid P component, protein S, and complement C4b with complement C4b-binding protein and subsequent association of the complex with membranes.

  1990cited by this paper
• Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus

  1989cited by this paper
• A pentameric form of human serum amyloid P component. Crystallization, X-ray diffraction and neutron scattering studies.

  1988cited by this paper
• Amyloid P component binds to keratin bodies in human skin and to isolated keratin filament aggregates in vitro.

  1988cited by this paper
• Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum.

  1987cited by this paper
• Human serum amyloid P component, a circulating lectin with specificity for the cyclic 4,6-pyruvate acetal of galactose. Interactions with various bacteria.

  1985cited by this paper
• Human serum amyloid P component. cDNA isolation, complete sequence of pre-serum amyloid P component, and localization of the gene to chromosome 1.

  1985cited by this paper
• Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component.

  1985cited by this paper
• Binding specificity of serum amyloid P component for the pyruvate acetal of galactose

  1984influential reference
• Calcium-dependent aggregation of human serum amyloid P component. Inhibition by the cyclic 4,6-pyruvate acetal of galactose.

  1984cited by this paper
• Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein.

  1983cited by this paper
• Localization of the phosphocholine-binding sites on C-reactive protein by immunoelectron microscopy.

  1983cited by this paper
• Calcium-dependent aggregation of human serum amyloid P component.

  1982influential reference
• PHYLOGENETIC ASPECTS OF C‐REACTIVE PROTEIN AND RELATED PROTEINS *

  1982cited by this paper
• Isolation of human C-reactive protein and serum amyloid P component.

  1982cited by this paper
• Use of n-Bromosuccinimide for the Iodination of Proteins for Radioimmunoassay

  1982cited by this paper
• Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component

  1981cited by this paper
• Isolation of serum amyloid P-component (protein SAP) in the mouse.

  1979cited by this paper
• Electron microscopy of serum amyloid protein in the presence of calcium; alternative forms of assembly of pentagonal molecules in two-dimensional lattices.

  1979cited by this paper
• Analogues in other mammals and in fish of human plasma proteins, C-reactive protein and amyloid P component

  1978cited by this paper
• Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.

  1978cited by this paper
• Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein.

  1977cited by this paper
• Isolation and study of murine C3.

  1977cited by this paper
• Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).

  1977cited by this paper
• The ultrastructure of C1t, a subcomponent of the first component of complement: an E.M. and ultracentrifuge study.

  1976cited by this paper

• Glycosylation‐Dependent Stability of Human Pentraxin‐2 Revealed by Surface‐Induced Dissociation and Ion Mobility Mass Spectrometry

  2025cites this paper
• Serum amyloid P secreted by bone marrow adipocytes drives skeletal amyloidosis

  2025cites this paper
• STRUCTURE AND PHYLOGENY OF PENTRAXINS Insights into the Evolutionary Relationships and Functional Architecture of Pentraxins

  2024cites this paper
• Exploring Intrinsic Disorder in Human Synucleins and Associated Proteins

  2024cites this paper
• Local Pentraxin-2 Deficit Is a Feature of Intestinal Fibrosis in Crohn’s Disease

  2023cites this paper
• Pentraxins in invertebrates and vertebrates: From structure, function and evolution to clinical applications.

  2023cites this paper
• Serum amyloid P component and pro-platelet basic protein in extracellular vesicles or serum are novel markers of liver fibrosis in chronic hepatitis C patients

  2022cites this paper
• Proteomics-Based Approach to Identify Novel Blood Biomarker Candidates for Differentiating Intracerebral Hemorrhage From Ischemic Stroke—A Pilot Study

  2021cites this paper
• Serum amyloid P component level is associated with clinical response to escitalopram treatment in patients with major depressive disorder.

  2021cites this paper
• Novel methods to determine complement activation in human serum induced by the complex of Dezamizumab and serum amyloid P

  2021cites this paper
• Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches.

  2020cites this paper
• Combined analysis of serum SAP and PRSS2 for the differential diagnosis of CD and UC.

  2020cites this paper
• Carbonic Anhydrase VI : Functional characterization in mouse and zebrafish model organisms

  2019cites this paper
• Penalized regression models to select biomarkers of environmental enteric dysfunction associated with linear growth acquisition in a Peruvian birth cohort

  2019cites this paper
• The long pentraxin PTX3 as a functional ancestor of antibodies in the immune response to Aspergillus fumigatus

  2019cites this paper
• An Improved Method for the Sensitive Detection of Shiga Toxin 2 in Human Serum

  2018cites this paper
• Combined Biomarkers Predict Acute Mortality Among Critically Ill Patients With Suspected Sepsis*

  2018cites this paper
• The Development of Serum Amyloid P as a Possible Therapeutic

  2018cites this paper
• The Pentraxins 1975–2018: Serendipity, Diagnostics and Drugs

  2018influential citation
• Identification of potential serum biomarkers of acute paraquat poisoning in humans using an iTRAQ quantitative proteomic

  2018cites this paper
• Levels of pentraxin-3 in gingival crevicular fluid of patients with aggressive and chronic periodontitis: An In Vivo study

  2018cites this paper
• The role of serum amyloid P in amyloidosis

  2018cites this paper
• Characterisation of molecular variations in human C-reactive protein

  2017cites this paper
• Serum Amyloid P Component (SAP) Interactome in Human Plasma Containing Physiological Calcium Levels.

  2017cites this paper
• Development of an assay to monitor the role of Serum Amyloid P-component in Alzheimer's Disease

  2016cites this paper
• Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro

  2016influential citation
• Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis

  2016cites this paper
• Serum Amyloid P Component and Systemic Fungal Infection: Does It Protect the Host or Is It a Trojan Horse?

  2016cites this paper
• Fibrocytes and Pulmonary Vascular Remodeling: The Good, the Bad, and the Progenitors

  2015cites this paper
• PLASMACYTOID DENDRITIC CELL-MEDIATED HUMORAL AUTOIMMUNITY

  2015cites this paper
• The Long Pentraxin PTX3 Promotes Fibrocyte Differentiation

  2015cites this paper
• Human Pentraxins Bind to Misfolded Proteins and Inhibit Production of Type I Interferon Induced by Nucleic Acid-Containing Amyloid.

  2015cites this paper
• A staggered decameric assembly of human C-reactive protein stabilized by zinc ions revealed by X-ray crystallography.

  2015cites this paper
• Interaction of serum amyloid P component with hexanoyl bis(d-proline) (CPHPC)

  2014cites this paper
• Native protein mapping and visualization of protein interactions in the area of human plasma high‐density lipoprotein by combining nondenaturing micro 2DE and quantitative LC‐MS/MS

  2014cites this paper
• Serum amyloid P: a systemic regulator of the innate immune response

  2014cites this paper
• Zur Rolle des langen Pentraxins PTX3 in der Pathogenese des Systemischen Lupus Erythematodes

  2014cites this paper
• Pentraxins: Structure, Function, and Role in Inflammation

  2013cites this paper
• Pentraxins: structure, function, and role in inflammation.

  2013cites this paper
• Monomerization of C‐reactive protein requires glycoprotein IIb‐IIIa activation: pentraxins and platelet deposition

  2013cites this paper
• NaCl Potentiates Human Fibrocyte Differentiation

  2012cites this paper
• FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation

  2012cites this paper
• SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice

  2012cites this paper
• Differentiation of circulating monocytes into fibroblast-like cells.

  2012cites this paper
• eVAluAtion of intrAthecAl sAp And crp synthesis in Alzheimer’s diseAse With the use of index VAlues

  2011cites this paper
• Evaluation of Intrathecal Serum Amyloid P (SAP) and C-Reactive Protein (CRP) Synthesis in Alzheimer's Disease with the Use of Index Values

  2011influential citation
• Structural basis of ligand specificity in the human pentraxins, C‐reactive protein and serum amyloid P component

  2011cites this paper
• C1, SAP and ZiCo : structural studies of three metal‑binding proteins from a crystallographic perspective

  2011influential citation
• Characterization of serum anyloid P and Fc gamma receptor: A critical engagement implicated in fibrosing diseases

  2011cites this paper
• Drug targets for amyloidosis.

  2010cites this paper
• Mise en évidence de l'interaction de la protéine tat du VIH-1 avec les pentraxines humaines : Impact sur la transcription du VIH et la différenciation des cellules dendritiques

  2010cites this paper
• A serum amyloid P‐binding hydrogel speeds healing of partial thickness wounds in pigs

  2009cites this paper
• Pentraxins, Anti-pentraxin Antibodies, and Atherosclerosis

  2009cites this paper
• Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component

  2009cites this paper
• Isolation of two C-reactive protein homologues from cod (Gadus morhua L.) serum.

  2009cites this paper
• Antibody-Array Interaction Mapping, a New Method to Detect Protein Complexes Applied to the Discovery and Study of Serum Amyloid P Interactions with Kininogen in Human Plasma*

  2009cites this paper
• Serum Amyloid P Inhibits Fibrosis Through FcγR-Dependent Monocyte-Macrophage Regulation in Vivo

  2009cites this paper
• Serum amyloid P inhibits dermal wound healing

  2008cites this paper
• Serum Amyloid P Component as a Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease

  2008cites this paper
• Reduction of Bleomycin-Induced Pulmonary Fibrosis by Serum Amyloid P1

  2007cites this paper
• Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease.

  2007cites this paper
• Chapter 6 Isolation and purification of human serum amyloid P component from donor blood by calcium-dependent affinity chromatography on pyruvate-rich agarose

  2007cites this paper
• Fibrosis by Serum Amyloid P Reduction of Bleomycin-Induced Pulmonary

  2007cites this paper
• Aggregated IgG inhibits the differentiation of human fibrocytes

  2006cites this paper
• Binding of human serum amyloid P componentto L‐selectin

  2006cites this paper
• Binding of Ca2+, Mg2+, and heparin by human serum amyloid P component in affinity capillary electrophoresis

  2006cites this paper
• Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility.

  2005cites this paper
• Ligand-assisted Aggregation of Proteins

  2005cites this paper
• Studies of serum amyloid P component (SAP) and antinuclear autoimmunity

  2004influential citation
• Concentration and separation of low-abundant proteins in human plasma by ammonium sulfate fractionation followed by a three-step electrophoresis technique

  2004cites this paper
• Investigating interactions of the pentraxins serum amyloid P component and C-reactive protein by mass spectrometry.

  2003cites this paper
• Serum Amyloid P Inhibition of Fibrocyte Differentiation by

  2003cites this paper
• Inhibition of Fibrocyte Differentiation by Serum Amyloid P 1

  2003cites this paper
• The structures of crystalline complexes of human serum amyloid P component with its carbohydrate ligand, the cyclic pyruvate acetal of galactose.

  2002cites this paper
• Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

  2002cites this paper
• Serum Amyloid P Component Does Not Circulate in Complex with C4‐Binding Protein, Fibronectin or Any Other Major Protein Ligand

  2002cites this paper
• Structural, Quantitative and Functional Comparison of Amyloid P Component in Sera from Patients with Systemic Lupus Erythematosus and Healthy Donors

  2002cites this paper
• The three-dimensional structure of calcium-depleted human C-reactive protein from perfectly twinned crystals.

  2002cites this paper
• Characterization of heparin binding by a peptide from amyloid P component using capillary electrophoresis, surface plasmon resonance and isothermal titration calorimetry.

  2002cites this paper
• Amilina: del estudio molecular a las acciones fisiológicas

  2001cites this paper
• Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies.

  2001cites this paper
• Bases moleculars de la diabetis tipus 2: Determinants genètics de l'amilina.

  2001cites this paper
• Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen.

  2000cites this paper